Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway

被引：0
|
作者：
He, Ming-ming [1 ]
Xu, Rui-hua [1 ]
Zhang, Dong-sheng [1 ]
Wang, Feng [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15028
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
  • [22] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Hunho Song
    Boram Han
    Choong Kee Park
    Jong Hyeok Kim
    Jang Yong Jeon
    In-Gyu Kim
    Hyo Jung Kim
    Joo Young Jung
    Jung Han Kim
    Jung Hye Kwon
    Geundoo Jang
    Ho Young Kim
    Hyeong Su Kim
    Dae Ro Choi
    Dae Young Zang
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 845 - 852
  • [23] Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naive patients with advanced gastric cancer
    Yamada, Y.
    Higuchi, K.
    Nishikawa, K.
    Gotoh, M.
    Fuse, N.
    Sugimoto, N.
    Nishina, T.
    Amagai, K.
    Chin, K.
    Niwa, Y.
    Tsuji, A.
    Imamura, H.
    Tsuda, M.
    Yasui, H.
    Fujii, H.
    Yamaguchi, K.
    Yasui, H.
    Hironaka, S.
    Shimada, K.
    Miwa, H.
    Hamada, C.
    Hyodo, I.
    ANNALS OF ONCOLOGY, 2015, 26 (01) : 141 - 148
  • [24] Randomized phase II study of S-1 plus oral leucovorin (SL) versus SL plus oxaliplatin (SOL) versus S-1 plus cisplatin (SP) in patients with advanced gastric cancer (AGC): Update data
    Komatsu, Y.
    Shuichi, H.
    Naotoshi, S.
    Kensei, Y.
    Toshikazu, M.
    Tomohiro, N.
    Akihito, T.
    Takako, E. N.
    Masahiro, G.
    Nozomu, M.
    Hideaki, B.
    Taito, E.
    Yasunori, E.
    Takashi, S.
    Shigemi, M.
    Narikazu, B.
    Hideo, B.
    Ichinosuke, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S447 - S447
  • [25] Randomized phase II study comparing S-1 plus Leucovorin (SL) versus S-1 alone in patients with gemcitabine-refractory advanced pancreatic cancer (APC)
    Okusaka, T.
    Ueno, M.
    Omuro, Y.
    Isayama, H.
    Fukutomi, A.
    Ikeda, M.
    Mizuno, N.
    Fukuzawa, K.
    Hyodo, I.
    Boku, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S611 - S611
  • [26] Erratum: Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    W Koizumi
    K Yamaguchi
    H Hosaka
    Y Takinishi
    N Nakayama
    T Hara
    K Muro
    H Baba
    Y Sasaki
    T Nishina
    N Fuse
    T Esaki
    M Takagi
    M Gotoh
    T Sasaki
    British Journal of Cancer, 2014, 111 : 2382 - 2382
  • [27] RETROSPECTIVE STUDY OF TREATMENT WITH S-1 ALONE OR S-1 PLUS CISPLATIN IN ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER
    Makiyama, C.
    Kajitani, T.
    Oda, H.
    Makiyama, A.
    Esaki, T.
    ANNALS OF ONCOLOGY, 2013, 24 : 35 - 35
  • [28] A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric cancer: Clinical and pharmacogenetic results
    Park, Sook Ryun
    Kim, Young Woo
    Ryu, Keun Won
    Lim, Hyeong-Seok
    Lee, Jun Ho
    Kong, Sun-Young
    Kim, Mi-Jung
    Choi, Mihee
    Park, Young Iee
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Randomized Phase II Trial of S-1 plus Irinotecan Versus S-1 plus Paclitaxel as First-line Treatment for Advanced Gastric Cancer (OGSG0402)
    Sugimoto, Naotoshi
    Fujitani, Kazumasa
    Imamura, Hiroshi
    Uedo, Noriya
    Iijima, Shohei
    Imano, Motohiro
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    Goto, Masahiro
    ANTICANCER RESEARCH, 2014, 34 (02) : 851 - 857
  • [30] Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer
    Ohkawa, S.
    Okusaka, T.
    Isayama, H.
    Fukutomi, A.
    Yamaguchi, K.
    Ikeda, M.
    Funakoshi, A.
    Nagase, M.
    Hamamoto, Y.
    Nakamori, S.
    Tsuchiya, Y.
    Baba, H.
    Ishii, H.
    Omuro, Y.
    Sho, M.
    Matsumoto, S.
    Yamada, N.
    Yanagimoto, H.
    Unno, M.
    Ichikawa, Y.
    Takahashi, S.
    Watanabe, G.
    Wakabayashi, G.
    Egawa, N.
    Tsuda, M.
    Hosotani, R.
    Hamada, C.
    Hyodo, I.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1428 - 1434
12345